Astellas Pharma US
Astellas Pharma US, Inc.
2375 Waterview Drive
Northbrook, IL 60062
Phone: (800) 727-7003Website: https://www.astellas.com/us/Careers: astellascareers.jobsPatient Assistance Program: astellaspharmasupportsolutions.com...
Latest news
- Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
26 January 2024 - Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
8 January 2024 - Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
15 December 2023 - FDA Approves Expanded Use of Cresemba (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
8 December 2023 - Pfizer and Astellas' Xtandi Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
16 November 2023 - Astellas Announces U.S. FDA Grants Priority Review for Zolbetuximab Biologics License Application
6 July 2023 - FDA Approves Veozah (fezolinetant) for the Treatment of Vasomotor Symptoms Due to Menopause
13 May 2023 - Results from Astellas' Phase 3 SPOTLIGHT Trial of Investigational Zolbetuximab Published in The Lancet
14 April 2023 - Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
21 March 2023 - Phase 3 Study Shows XTANDI plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
17 March 2023
Drugs Associated with Astellas Pharma US, Inc.
Astellas Pharma US, Inc. manufactures, markets and/or distributes more than 13 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Astagraf XL
Generic name: tacrolimus Drug class: calcineurin inhibitors |
||
|
Cresemba
Generic name: isavuconazonium Drug class: azole antifungals |
1 review | 5.0 / 10 |
|
Lexiscan
Generic name: regadenoson Drug class: cardiac stressing agents |
30 reviews | 5.3 / 10 |
|
Mycamine
Generic name: micafungin Drug class: echinocandins |
||
|
Myrbetriq
Generic name: mirabegron Drug class: urinary antispasmodics |
251 reviews | 4.9 / 10 |
|
Padcev
Generic name: enfortumab vedotin Drug class: miscellaneous antineoplastics |
2 reviews | 1.0 / 10 |
|
Prograf
Generic name: tacrolimus Drug class: calcineurin inhibitors |
24 reviews | 8.0 / 10 |
|
Veozah
Generic name: fezolinetant Drug class: miscellaneous central nervous system agents |
9 reviews | 7.8 / 10 |
|
VESIcare
Generic name: solifenacin Drug class: urinary antispasmodics |
133 reviews | 5.5 / 10 |
|
VESIcare LS
Generic name: solifenacin Drug class: urinary antispasmodics |
||
|
Xospata
Generic name: gilteritinib Drug class: multikinase inhibitors |
1 review | 8.0 / 10 |
|
Xtandi
Generic name: enzalutamide Drug class: antiandrogens, hormones/antineoplastics |
19 reviews | 5.4 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
